GoHealth, Inc.

GoHealth, Inc. (the “Company”) was unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”) within the prescribed time period without unreasonable effort or expense. The Company is engaged in ongoing discussions with its lenders and other stakeholders regarding strategic alternatives to address the Company’s capital structure and liquidity position. Such alternatives may involve a change of control or other restructuring of the Company. In light of the uncertainty related to such discussions, additional time was required for the Company to compile and analyze certain information and documentation and to finalize certain disclosures required to be included in the Form 10-Q. Management will disclose in the Form 10-Q that there is substantial doubt about the Company’s ability to continue as a going concern. The Company is filing the Form 10-Q substantially concurrently with this Form 12b-25 on May 18, 2026

The Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the “Quarterly Report”) of GoHealth, Inc. (the “Company”) could not be filed with the Securities and Exchange Commission within the prescribed time period without unreasonable effort or expense. The delay in filing is necessary to allow adequate time for management to perform its review and assessment of certain financial and other related data and the disclosures required in connection therewith, as described in further detail in the paragraphs below. As of March 31, 2025, the Company is in compliance with all of its financial covenants contained in its credit facilities. However, management’s current financial projections indicate that, based on the Company’s current business plan, there is a significant likelihood that the Company will be unable to maintain compliance with its covenants and make scheduled principal and interest payments, including amounts due under the Class A Revolving Facility expiring on June 30, 2025, within the twelve months after the date the Quarterly Report is filed, unless the mitigating plans described below are implemented successfully. If the Company is unable to meet its covenants or make scheduled principal and interest payments, the Company’s lenders could declare the Company in default and accelerate all amounts owing under the credit facilities. The Company does not expect it would have sufficient liquidity to repay such amounts. Management has developed mitigating plans to address the potential liquidity constraints, including cost control measures and renegotiation of the terms of its existing debt arrangements. However, the Company cannot provide assurance that it will be successful in implementing these mitigating plans on acceptable terms, if at all. As a result, there is substantial doubt about the Company’s ability to continue as a going concern

Due to technical difficulties encountered while submitting its Quarterly Report on Form 10-Q for the three months ended June 30, 2022 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) through third-party filing software, the registrant’s submission of the Form 10-Q was not timely completed until after 5:30 p.m. ET on August 15, 2022. The 10-Q was accepted by the SEC at 5:50 p.m. ET on August 15, 2022

GoHealth, Inc. (the “Company”) has determined that it is unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 (the “Form 10-K”) within the prescribed time period without unreasonable effort or expense for those reasons set forth below. On December 31, 2021, the Company’s status as an emerging growth company ended and the Company became a large accelerated filer. As a result, the Company (i) is subject to a shortened filing deadline of 60 rather than 90 days to file the Form 10-K following the end of the Company’s annual reporting period and (ii) is, for the first time, subject to the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “SOX Act”). In connection with this shorter filing timeline and the enhanced compliance obligations with respect to Section 404 of the SOX Act, the Company requires additional time to complete the assessment of the Company’s internal controls over financial reporting as of December 31, 2021, and to quantify an expected goodwill impairment charge anticipated to be completed in connection with the finalization of the Form 10-K. The Company expects to file the Form 10-K within the extension period of 15 calendar days as provided by Rule 12b-25 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)